These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21618900)

  • 1. Chronic myelogenous leukemia in the chronic phase with lymph node swelling which represented extramedullary involvement composed of cells at different stages of maturation.
    Kobayashi Y; Tanaka T; Kawata E; Akaogi T
    Rinsho Byori; 2011 Apr; 59(4):360-3. PubMed ID: 21618900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case of chronic-phase chronic myelogenous leukemia with an abdominal hematopoietic tumor of leukemic clone origin.
    Sakakura M; Ohishi K; Nomura K; Katayama N; Nishii K; Masuya M; Nakase K; Shiku H
    Am J Hematol; 2004 Oct; 77(2):167-70. PubMed ID: 15389905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Extramedullary blastic crisis of chronic myelogenous leukemia--a case with various additional chromosomal appearance].
    Nakao Y; Ohta T; Koh K; Hashimoto S; Takekawa K; Hirai N; Tanaka K; Hasuike T; Hirai M; Ohta K
    Rinsho Byori; 1994 Apr; 42(4):425-9. PubMed ID: 8176852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sudden extramedullary T-lymphoblastic blast crisis in chronic myelogenous leukemia: a nonrandom event associated with imatinib?
    Kim AS; Goldstein SC; Luger S; Van Deerlin VM; Bagg A
    Am J Clin Pathol; 2008 Apr; 129(4):639-48. PubMed ID: 18343792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Extramedullary blast crisis of mixed precursor T lymphoblastic and myeloblastic features in a patient with chronic myelogenous leukemia successfully treated with low-dose oral etoposide].
    Konaka Y; Namiuchi S
    Rinsho Ketsueki; 1993 Dec; 34(12):1556-61. PubMed ID: 8295329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
    Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY
    Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of imatinib mesylate, a specific inhibitor of BCR/ABL tyrosine kinase, on chronic myeloid leukemia in blast phase].
    Zhang GC; Zheng D; Li QH; Li XH; Cai CC; Luo SK; Li J; Peng AH; Tong XZ; Tan EX; Hong WD
    Ai Zheng; 2004 Dec; 23(12):1696-9. PubMed ID: 15601563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.
    Qing X; Qing A; Ji P; French SW; Mason H
    Exp Mol Pathol; 2018 Apr; 104(2):130-133. PubMed ID: 29501750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-up.
    Palandri F; Castagnetti F; Testoni N; Luatti S; Marzocchi G; Bassi S; Breccia M; Alimena G; Pungolino E; Rege-Cambrin G; Varaldo R; Miglino M; Specchia G; Zuffa E; Ferrara F; Bocchia M; Saglio G; Pane F; Alberti D; Martinelli G; Baccarani M; Rosti G;
    Haematologica; 2008 Dec; 93(12):1792-6. PubMed ID: 18838477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biphenotypic extramedullary blast crisis as a presenting manifestation of Philadelphia chromosome-positive CML in a child.
    Ganessan K; Goel R; Kumar K; Bakhshi S
    Pediatr Hematol Oncol; 2007; 24(3):195-8. PubMed ID: 17454789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reversion to chronic phase of chronic myelogenous leukemia in blast crisis with small-dose daunorubicin and oral prednisolone].
    Kuyama J; Take H
    Rinsho Ketsueki; 1995 Dec; 36(12):1353-8. PubMed ID: 8587171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Extramedullary blast crisis in chronic myeloid leukemia].
    Cervantes F; Rozman M; Nicolás JM; López Guillermo A; Rozman C
    Sangre (Barc); 1989 Apr; 34(2):96-8. PubMed ID: 2756456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological fracture as a manifestation of extramedullary blastic crisis in chronic myelogenous leukemia: report of one case.
    Yu HH; Lu MY; Lin DT; Lin KH; Tang JL; Jou ST
    Acta Paediatr Taiwan; 2006; 47(3):150-4. PubMed ID: 17078470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imatinib mesylate as treatment for blastic transformation of Philadelphia chromosome positive chronic myelogenous leukemia.
    Sureda A; Carrasco M; de Miguel M; Martínez JA; Conde E; Sanz MA; Díaz-Mediavilla J; Sierra J
    Haematologica; 2003 Nov; 88(11):1213-20. PubMed ID: 14607749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of extramedullary blast crisis of chronic myelogenous leukemia with imatinib mesylate (STI571).
    Naito K; Mori T; Miyazaki K; Tsukada Y; Ikeda Y; Okamoto S
    Intern Med; 2003 Aug; 42(8):740-2. PubMed ID: 12924504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lymph node involvement as a primary localization of extramedullary blast crisis of chronic granulocytic leukemia (PBS)].
    Kuliszkiewicz-Janus M; Haus O
    Acta Haematol Pol; 1993; 24(1):65-70. PubMed ID: 8488739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia.
    Soverini S; Martinelli G; Rosti G; Bassi S; Amabile M; Poerio A; Giannini B; Trabacchi E; Castagnetti F; Testoni N; Luatti S; de Vivo A; Cilloni D; Izzo B; Fava M; Abruzzese E; Alberti D; Pane F; Saglio G; Baccarani M
    J Clin Oncol; 2005 Jun; 23(18):4100-9. PubMed ID: 15867198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph node blast crisis in chronic myeloid leukemia mimicking T-immunoblastic lymphoma.
    Leone G; La Rocca LM; Teofili L; De Candia E; Landolfi R; Sica S; Zini G; Zollino M; Tabilio A
    Haematologica; 1992; 77(4):311-4. PubMed ID: 1427440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the impact of imatinib mesylate therapy on the prognosis of patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha regimens for early chronic phase.
    Kantarjian H; O'Brien S; Cortes J; Shan J; Giles F; Garcia-Manero G; Verstovsek S; Faderl S; Rios MB; Talpaz M
    Cancer; 2003 Oct; 98(7):1430-7. PubMed ID: 14508830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up results.
    Kantarjian HM; Talpaz M; O'Brien S; Smith TL; Giles FJ; Faderl S; Thomas DA; Garcia-Manero G; Issa JP; Andreeff M; Kornblau SM; Koller C; Beran M; Keating M; Rios MB; Shan J; Resta D; Capdeville R; Hayes K; Albitar M; Freireich EJ; Cortes JE
    Clin Cancer Res; 2002 Jul; 8(7):2177-87. PubMed ID: 12114418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.